- Home
- FULC vs ALTI Comparison
FULC vs ALTI Comparison
Compare FULC & ALTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FULC
- ALTI
- Stock Information
- Founded
- FULC 2015
- ALTI 2020
- Country
- FULC United States
- ALTI United States
- Employees
- FULC N/A
- ALTI N/A
- Industry
- FULC Biotechnology: Pharmaceutical Preparations
- ALTI Investment Managers
- Sector
- FULC Health Care
- ALTI Finance
- Exchange
- FULC Nasdaq
- ALTI Nasdaq
- Market Cap
- FULC 469.0M
- ALTI 388.9M
- IPO Year
- FULC 2019
- ALTI N/A
- Fundamental
- Price
- FULC $9.02
- ALTI $3.95
- Analyst Decision
- FULC Buy
- ALTI
- Analyst Count
- FULC 7
- ALTI 0
- Target Price
- FULC $10.43
- ALTI N/A
- AVG Volume (30 Days)
- FULC 578.7K
- ALTI 89.6K
- Earning Date
- FULC 10-29-2025
- ALTI 11-10-2025
- Dividend Yield
- FULC N/A
- ALTI N/A
- EPS Growth
- FULC N/A
- ALTI N/A
- EPS
- FULC N/A
- ALTI N/A
- Revenue
- FULC N/A
- ALTI $217,760,000.00
- Revenue This Year
- FULC N/A
- ALTI $19.78
- Revenue Next Year
- FULC N/A
- ALTI $7.00
- P/E Ratio
- FULC N/A
- ALTI N/A
- Revenue Growth
- FULC 2752.05
- ALTI N/A
- 52 Week Low
- FULC $2.32
- ALTI $2.33
- 52 Week High
- FULC $10.11
- ALTI $5.00
- Technical
- Relative Strength Index (RSI)
- FULC 51.00
- ALTI 56.89
- Support Level
- FULC $8.42
- ALTI $3.71
- Resistance Level
- FULC $10.09
- ALTI $4.02
- Average True Range (ATR)
- FULC 0.82
- ALTI 0.15
- MACD
- FULC -0.12
- ALTI 0.03
- Stochastic Oscillator
- FULC 40.56
- ALTI 84.09
About FULC Fulcrum Therapeutics Inc.
Fulcrum Therapeutics Inc is a clinical-stage biopharmaceutical company. The company's programs in clinical development are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystrophy (FSHD) and FTX-6058, a small molecule designed to increase expression of fetal hemoglobin for the treatment of sickle cell disease and other hemoglobinopathies, including beta-thalassemia.
About ALTI AlTi Global Inc.
AlTi Global Inc is an independent wealth and asset manager providing entrepreneurs, multi-generational families, institutions, and emerging next-generation leaders with fiduciary capabilities as well as alternative investment strategies and advisory services. The firm has business which is organized into two business segments namely: Wealth & Capital Solutions and International Real Estate segment includes providing holistic solutions for wealth management clients through comprehensive range of wealth management services, including investment management and advisory services. International Real Estate segment includes assist investors with real estate co-investments, structuring and selecting partners with a proven track record with risk adjusted return characteristics.